Samsung Electronics Finalizes Xealth Acquisition for Digital Health App

Samsung Electronics has finalized its acquisition of Xealth, a digital health prescription platform that enables physicians to prescribe and manage digital health apps. The agreement, initially announced in July, marks Samsung’s latest move to strengthen its presence in healthcare technology. Xealth will continue to operate under its existing brand and leadership team.

Xealth’s platform integrates digital health offerings directly into clinical workflows, helping health systems improve patient care and operational efficiency. Its suite of tools includes multimedia patient education, digital clinical assessments, remote patient monitoring programs, virtual care referrals, and other services designed to prepare, assess, and support patients throughout their care journeys. Xealth’s Digital Care SMART on FHIR app allows physicians and care teams to order, deliver, and monitor digital health tools directly from the EHR, supported by clinical decision intelligence that matches patients with relevant programs. The app can be downloaded from EHR app stores and configured to launch within the provider’s charting workflow, leveraging EHR data to automatically suggest and enroll patients into appropriate digital programs.

Dr. Hon Pak, senior vice president and head of the digital health team at Samsung Electronics’ mobile eXperience business, said the partnership would help build a more connected healthcare ecosystem aimed at improving health outcomes for all. Xealth CEO and cofounder Mike McSherry added that the acquisition strengthens the company’s mission to enhance the bond between care teams and patients through familiar technologies. Together with Samsung, Xealth aims to bridge home health monitoring and clinical decision-making, keeping provider workflows and the patient-provider relationship central to its efforts.

The acquisition builds on Samsung’s broader strategy to expand its footprint in healthcare technology. In 2024, the company signed a three-year contract with South Korean medical AI provider Lunit to integrate AI-powered chest X-ray solutions—Lunit INSIGHT CXR and Lunit INSIGHT CXR Triage—into Samsung’s premium X-ray devices across the U.S., Canada, and Europe. Similarly, in 2021, Samsung partnered with AI developer VUNO to incorporate its diagnostic solutions into Samsung’s premium mobile and ceiling-mounted digital radiography systems. These collaborations reflect Samsung’s ongoing commitment to embedding AI and digital innovation into medical imaging and healthcare delivery.

Xealth, meanwhile, has continued expanding its presence within health systems. In March, it secured strategic investment from Morningside Ventures to grow its digital health portfolio and help providers manage and deploy digital health formularies more efficiently. The company also partnered with the Froedtert & Medical College of Wisconsin health network to deliver clinically driven nutrition services through Season Health, targeting diabetes management and improved chronic care outcomes.

Through the acquisition, Samsung and Xealth plan to combine their technological and clinical expertise to create a more integrated and intelligent healthcare ecosystem, advancing digital care delivery and patient engagement on a global scale.